OpenAlex
PricingAboutJobs
Log inGet started
Author

S. Kawakami

Observed name: Satoru Kawakami
Institutions: Saitama Medical Center, Saitama Medical University, Saitama Medical University
Observed institutions: Saitama Medical Center, Saitama Medical University, Saitama Medical University
ORCID: 0000-0001-6319-3821
Observed ORCID: 0000-0001-6319-3821
OpenAlex ID: A5015379188
142P The predictive biomarker for immune-related adverse events (irAEs) in patients with metastatic renal cell carcinoma treated with the combination therapy of nivolumab plus ipilimumab: Musashino study-irAE
2022 · R. Kizawa, M. Kuno, et al. · Annals of Oncology · 2
PDF
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High‐Risk Metastatic Hormone‐Naïve Prostate Cancer: Results From a 3‐Year Interim Analysis of the J‐ROCK Study
2026 · Atsushi Mizokami, Rikiya Matsumoto, et al. · The Prostate · 1
PDF
144P Association between immune-related adverse events and survival in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
2022 · T. Hayase, S. Washino, et al. · Annals of Oncology · 1
PDF
139MO Prognostic significance of the mechanism of inflammatory markers in advanced renal cell carcinoma patients treated with nivolumab plus ipilimumab
2022 · T. Nakayama, H. Takeshita, et al. · Annals of Oncology
Works count: 4
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms